| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000003150 |
| Receipt No. | R000003823 |
| Scientific Title | Clinical research of HPV infection in head and neck squamous cell carcinoma |
| Date of disclosure of the study information | 2010/03/01 |
| Last modified on | 2022/09/29 (Ver. 3) |
| Basic information | ||
| Public title | Clinical research of HPV infection in head and neck squamous cell carcinoma | |
| Acronym | HPV infection in head and neck cancer | |
| Scientific Title | Clinical research of HPV infection in head and neck squamous cell carcinoma | |
| Scientific Title:Acronym | HPV infection in head and neck cancer | |
| Region |
|
|
| Condition | ||
| Condition | Head and neck squamous cell carcinoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To clarify how HPV involved in head and neck cancer
To clarify relationship between HPV infection and clinical prognosis To find the usefulness of brushing examination for HPV detection To perform HPV genotyping in head and neck cancer |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Prevalence of HPV infection
Association between HPV infection and clinical factors Detection rate of brushing examination for HPV infection |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients diagnosed oropharyngeal squamous cell carcinoma by pathological examination
The patients over 12 years old who underwent tonsillectomy due to habitual tonsillitis or hypertrophy of tonsil |
|||
| Key exclusion criteria | Nothing in particular | |||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Eiju General Hospital | ||||||
| Division name | Department of Otorarhingology | ||||||
| Zip code | 1108645 | ||||||
| Address | 2-23-16 Higashiueno Taitouku Tokyo Japan | ||||||
| TEL | 03-3833-8381 | ||||||
| entmafuji@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Eiju General Hospital | ||||||
| Division name | Otolaryngology | ||||||
| Zip code | 1108645 | ||||||
| Address | 2-23-16 Higashiueno Taitouku Tokyo Japan | ||||||
| TEL | 03-383-8381 | ||||||
| Homepage URL | |||||||
| entmafuji@gmail.com | |||||||
| Sponsor | |
| Institute | National Hospital Organization Tokyo Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Hospital Organization Tokyo Medical Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Society of basic research for head and neck cancer |
| Name of secondary funder(s) | Research Center |
| IRB Contact (For public release) | |
| Organization | NTMC |
| Address | Meguro Tokyo Japan |
| Tel | 03-3411-0111 |
| entmafuji@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Weclarify how HPV involved in head and neck cancer. Patients with oropharygeal cancer is enrolled. We clarify the relationship between HPV infection and clinical prognosis. We perform HPV genotyping in head and neck cancer. The normal tosil wil be also examined.
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000003823 |